Abstract Purpose Circulating tumor cells (CTCs) represent an independent prognostic factor
in metastatic colorectal cancer, while their significance in early stages is still an open issue …

Background Several studies have shown, that circulating tumor cells (CTC) have a negative
prognostic value in colorectal cancer patients. Aim of this study was to evaluate the role of …

Simple Summary The ability to predict or detect colorectal cancer (CRC) recurrence early
after surgery enables physicians to apply appropriate treatment plans and different follow-up …

Introduction Liquid biopsies allowing for individualized risk stratification of cancer patients
have become of high significance in individualized cancer diagnostics and treatment. The …

Purpose The aim of this study was to investigate the role of circulating tumor cells (CTCs) in
assessing and predicting tumor response to neoadjuvant chemoradiotherapy (CRT) for …

The aim of this study was to evaluate the prognostic value of circulating tumor cells (CTC) in
nonmetastatic rectal cancer patients treated with short‐term preoperative radiotherapy. In …

This is the first study that seeks to establish the prognostic value of circulating tumor cell
(CTC)(determined by CellSearch system) in patients with stage III CRC. Our results suggest …

Background: Circulating tumour cells (CTC) in the blood have been accepted as a
prognostic marker in patients with metastatic colorectal cancer (CRC). Only limited data exist …

Background: The role of adjuvant chemotherapy after resection of colorectal cancers (CRCs)
is well understood for patients with stage-I or stage-III disease. Its efficacy for those with …

The identification of patients at higher risk of recurrence after primary colorectal cancer
resection is currently one of the challenges facing medical oncologists. Circulating tumor cell …